Viral Genetics, Inc. (vral) - Financial And Strategic Analysis Review --- Aarkstore Enterprise

Viral Genetics, Inc

Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review

Viral Genetics, Inc. (Viral Genetics) is a biotechnology company, engaged in the discovery, development and commercialization of immune based therapies using its thymus nuclear protein compound for the treatment of serious diseases and autoimmune conditions. Viral Genetics is focused on developing therapies to treat HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. The lead product candidate of Viral Genetics is VGV-1, which is being studied in clinical trials for the treatment for HIV infection and AIDS. The company is headquartered in San Marino, California, the US.

Viral Genetics, Inc. Key Recent Developments

Apr 19, 2010: Viral Genetics Opens Lab In Texas

Dec 08, 2009: Viral Genetics Enters Into Exclusive License Agreement With University of Colorado

Mar 18, 2009: Viral Genetics Receives Grant From TTC For Lyme Research Study

This comprehensive SWOT profile of Viral Genetics, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Viral Genetics, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit :

http://www.aarkstore.com/reports/Viral-Genetics-Inc-VRAL-Financial-and-Strategic-Analysis-Review-51765.html

by: Aarkstore Enterprise

POST COMMENT

Cordex Pharma, Inc. (cdxp) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Myriad Pharmaceuticals Inc Myrx Financial And Strategic Analysis Review --- Aarkstore Enterprise Wholesale Dvds: Where You Can Get Them Genexine Co., Ltd. (95700) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise--indoco Remedies Limited (532612) - Financial And Strategic Analysis Review Zhongtian International Limited (2379) - Financial And Strategic Analysis Review --- Aarkstore Giaconda Limited (gia) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Cytodyn, Inc. (cydy) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Intellect Neurosciences, Inc. (ilns) - Financial And Strategic Analysis Review --- Aarkstore Qrxpharma Limited (qrx) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Omeros Corporation (omer) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Sosei Co. Ltd. (4565) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Laboratorios Farmaceuticos Rovi, S.a. (rovi) - Financial And Strategic Analysis Review --- Aarkstore